Recombinant Human PRKG2 Protein, N-His

Description of Recombinant Human PRKG2 Protein, N-His

Introduction to Recombinant Human PRKG2 Protein

Recombinant Human PRKG2 Protein, also known as cGMP-dependent protein kinase 2, is a member of the protein kinase family. This protein plays a crucial role in various cellular processes, including smooth muscle relaxation, platelet function, and neuronal signaling. The recombinant form of this protein is produced through genetic engineering techniques, making it a valuable tool for research and therapeutic applications.

Structure of Recombinant Human PRKG2 Protein

The recombinant form of PRKG2 is a 75 kDa protein consisting of 671 amino acids. It contains a catalytic domain, a regulatory domain, and a leucine zipper motif. The catalytic domain is responsible for the phosphorylation of target proteins, while the regulatory domain acts as an autoinhibitory domain. The leucine zipper motif is involved in protein-protein interactions and plays a role in the dimerization of PRKG2.

Activity of Recombinant Human PRKG2 Protein

Recombinant Human PRKG2 Protein is a serine/threonine kinase that is activated by the second messenger cyclic guanosine monophosphate (cGMP). Upon activation, PRKG2 phosphorylates target proteins, leading to changes in their activity and function. This protein is involved in various signaling pathways, including the nitric oxide-cGMP pathway, which regulates smooth muscle relaxation, and the cGMP-PDE5 pathway, which regulates platelet function.

One of the key activities of PRKG2 is its role in smooth muscle relaxation. This protein is expressed in smooth muscle cells and is activated by cGMP, leading to the phosphorylation of target proteins involved in the relaxation of these cells. This activity is crucial in maintaining normal blood pressure and preventing conditions such as hypertension.

In addition to its role in smooth muscle relaxation, PRKG2 also plays a role in platelet function. Platelets are small blood cells involved in blood clotting. Upon activation, PRKG2 phosphorylates target proteins involved in platelet activation, leading to a decrease in platelet aggregation and clot formation. This activity is important in preventing conditions such as heart attacks and strokes.

Applications of Recombinant Human PRKG2 Protein

Recombinant Human PRKG2 Protein has various applications in both research and therapeutic settings. In research, this protein can be used to study the role of PRKG2 in different cellular processes, such as smooth muscle relaxation and platelet function. It can also be used to investigate the effects of mutations in the PRKG2 gene and their impact on protein function.

In therapeutic applications, recombinant PRKG2 can be used as a potential treatment for conditions such as hypertension and cardiovascular diseases. By targeting the cGMP-PDE5 pathway, recombinant PRKG2 can regulate platelet function and prevent blood clot formation. This protein can also be used to develop drugs that target the nitric oxide-cGMP pathway, which is involved in smooth muscle relaxation.

Conclusion

Recombinant Human PRKG2 Protein is a vital tool for understanding the role of PRKG2 in various cellular processes. Its structure, activity, and applications make it a valuable protein for both research and therapeutic purposes. By targeting the cGMP-PDE5 and nitric oxide-cGMP pathways, recombinant PRKG2 has the potential to treat conditions such as hypertension and cardiovascular diseases. Further research on this protein may lead to the development of new and effective treatments for these conditions.